227 results on '"Zakliczynski, M."'
Search Results
52. Utility of Gene Expression Profiling Test (GEP) Score Instability To Predict Future Clinical Outcomes in Heart Transplant: Results from the CARGO 2 European-Based Multicenter Trial
53. Persisting Mild Lesions in Coronary Angiography Prognosticate Poor Long-Term Survival of Heart Transplant Recipients
54. Comparison of Surgical Wound Infection Etiology in Patients Treated with Short-Term Pulsatile Mechanical Circulatory Support, Receiving Heart Transplant, or Undergoing Other Cardiac Surgery Procedure
55. Formation of Insoluble Advanced Glycation End Products Deposits in Connective Tissue of Hearts Explanted Prior to Transplantation Is Enhanced both by Heart Failure and Diabetes
56. 81 Prediction of Allograft Clinical Outcomes and Risk of Acute Cellular Rejection with a Non-Invasive Gene-Expression Profiling Test (AlloMap): Results from the Cargo 2 European-Based Multicenter Trial
57. Paradox of Advanced Glycation End-Products in Late Cardiac Biopsies of Heart Transplant Recipients
58. In the Era of the Universal Use of Statins Dyslipidemia's are Still Common in Heart Transplant Recipients: A Cross-Sectional Study
59. 575 Absence of Restrictive Pattern in Spirometry (PFT) Predicts Good Survival in Chronic Heart Failure (CHF) Patients with Peak Oxygen Consumption(PekVO2) below the Cutoff Point for Heart Transplantation Listing
60. 200 Perioperative Sildenafil Administration Decreases the Risk of Early Death Due to the Transplanted Heart Right Ventricle Failure
61. 573 Chronic Heart Failure (CHF) Patients with Cardiopulmonary Exercise Test (CPX) Result Suggesting Only Probable Indications for OHT Are at High Risk of Death When Abnormalities in Spirometry (PFT) Occur
62. (861) - Influence of Proliferation Signal Inhibitors on Vascular Endothelial Growth Factor Production in Heart Transplant Recipients
63. PATIENTS ON LONG-TERM BETACEPTOR-ANTAGONIST TREATMENT WITH PEAK OXYGEN CONSUMPTION ABOVE THE CUT-OFF POINT FOR HEART TRANSPLANTATION LISTING HAVE WORSE SURVIVAL IF A RESTRICTIVE PATTERN IN LUNG FUNCTION TESTS OCCURES
64. THE EFFECT OF EVEROLIMUS INTRODUCTION ON RENAL FUNCTION IN HEART TRANSPLANT RECIPIENTS
65. ADVANCED GLYCATION END-PRODUCTS (AGES) IN LATE PATHOLOGY OF TRANSPLANTED HEART IN PATIENTS WITH OR WITHOUT DIABETES MELLITUS TYPE 2 (DM).
66. DO HEART TRANSPLANT RECIPIENTS WITH PULMONARY HYPERTENSION BENEFIT FROM PERIOPERATIVE ORAL SILDENAFIL TREATMENT?
67. EARLY STEROID WITHDRAWAL HAS BAD IMPACT ON DIABETES MELLITUS (DM) AND KIDNEY FUNCTION
68. Poster Session 4: Miscellaneous
69. 93: Efficacy of Treatment with Pulsatile Pump as a Bridge to Transplantation in Patients with a Congestive Heart Failure – Polish Experiences with POLVAD
70. 473: Inter-Observer Variability in the Interpretation of Cardiac Biopsies Remains a Challenge: Results of the Cardiac Allograft Rejection Gene Expression Observational (CARGO) II Study
71. 323: Influence of Sirolimus on Survival in Heart Transplant Recipients
72. HOW TO USE SIROLIMUS IN ORDER TO INCREASE SURVIVAL IN HEART TRANSPLANT RECIPIENTS?
73. SURVIVAL BENEFIT IN HEART TRANSPLANT RECIPIENTS WITH CORONARY ARTERY DISEASE CONFIRMED IN ANGIOGRAPHY RECEIVING SIROLIMUS
74. ADVANCED GLYCATION END-PRODUCTS (AGES) IN DEVELOPMENT OF ISCHEMIC AND DILATED CARDIOMYOPATHY IN PATIENTS WITH DIABETES MELLITUS TYPE 2 (DM)
75. FLUCTUATIONS OF EXERCISE CAPACITY IN PATIENTS AFTER KIDNEY TRANSPLANTATION
76. CARDIOCYTE NUCLEAR CHROMATIN DENSITY CORRELATES WITH TRANSPLANTED HEART LEFT VENTRICULAR MASS
77. Comparison of different strategies utilizing sirolimus to avoid renal failure in heart transplant recipients
78. 520: Superior Results of Drug Eluting Stent (DES) Compared with Bare Metal Stent (BMS) Implantation in Heart Transplant Recipients with Coronary Artery Disease
79. Elective Conversion from CellCept to Myfortic Under Control of Mycophenolic Acid Concentration in Stable Heart Transplant Recipients
80. 267: Presence of lipofuscin deposition in cardiomyocytes but not vascular abnormalities observed in endomyocardial biopsies (EMBs) predicts development of transplanted heart coronary artery vasculopathy (CAV)
81. 23: Quilty effect (QE) correlates with biopsy proven acute cellular rejection but does not predict transplanted heart coronary artery vasculopathy (CAV)
82. 262: Is intramyocardial macrophage infiltration beneficial in heart failure secondary to non-ischemic cardiomyopathy?
83. 208 Quilty effect occurs in heart transplant recipients with higher risk of significant cellular rejection development
84. Tu-P10:477 Vascular chimerism of human cardiac allograft is the result of inflammatory response
85. 214 Is an exercise valuable to achieve standardized NT-proBNP measurement in the heart transplant candidates?
86. 205 Thymoglobuline administered early after heart transplantation (OHT) protects myocardial hypertrophy assessed by karyometric studies
87. COMPARISON OF EARLY FUNCTION OF HEART AND KIDNEYS HARVESTED FROM THE SAME DONOR AND TRANSPLANTED INTO DIFFERENT RECIPIENTS
88. USEFULNESS OF STANFORD SCALE OF INTIMAL HYPERPLASIA ASSESSED BY INTRAVASCULAR ULTRASOUND TO PREDICT TIME OF ONSET AND SEVERITY OF TRANSPLANTED HEART CORONARY ARTERY DISEASE.
89. USEFULNESS OF PULMONARY HYPERTENSION REVERSIBILITY TEST WITH SODIUM NITROPRUSSIDE (NPS) IN STRATIFICATION OF EARLY DEATH RISK AFTER ORTHOTOPIC HEART TRANSPLANTATION (OHT).
90. LONGER ISCHAEMIC TIME CAUSED BY A DISTANCE BETWEEN THE DONOR HOSPITAL AND TRANSPLANT CENTER DOES NOT INFLUENCE SHORT AND LONG TERM RESULTS OF HEART TRANSPLANTATION
91. INFLUENCE OF IMMUNOPHILLINS INHIBITORS – CYCLOSPORINE-A, TACROLIMUS AND RAPAMYCIN – ON INSULIN SECRETION IN HEART TRANSPLANT RECIPIENTS WITH DIABETES.
92. THE APOPTOSIS-RELATED SOLUBLE MOLECULES CONCENTRATION IN HEART TRANSPLANT RECIPIENTS RECEIVING TACROLIMUS OR CYCLOSPORINE-A – PILOT STUDY.
93. CHIMERISM OF HUMAN CARDIAC ALLOGRAFT
94. FACTORS INFLUENCING TIME OF ONSET OF TRANSPLANTED HEART CORONARY ARTERY DISEASE.
95. CLUE FACTORS IN ACHIEVEMENT OF 10-YEAR SURVIVAL AFTER ORTHOTOPIC HEART TRANSPLANTATION (OHT).
96. (759) - Performance of Gene Expression Profiling Variability in Discriminating Heart Transplant Patients at Risk for Future Clinical Events
97. Clinical application of monitoring mycofenolic acid (MPA) concentration in heart transplant recipients - preliminary report
98. Surgical wound-healing complications in heart transplant recipients treated with rapamycin.
99. Consensus concerning diagnostics, prophylaxis and treatment of CMV infection in immunocompromised patients,Uzgodnienia w sprawie rozpoznawania, profilaktyki i leczenia zakazen wirusem cytomegalii (CMV) u chorych z immunosupresja
100. Usefulness of Troponin-T and myoglobin measurements in the diagnosis of perioperative myocardial infarction. Preliminary results,Troponina-T i mioglobina w diagnostyce srodoperacyjnego uszkodzenia niedokrwiennego miesnia sercowego
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.